A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to TTAM Research Institute, a nonprofit organization led by 23andMe's co-founder and former CEO Anne Wojcicki, replacing a previous $256 million bid from Regeneron Pharmaceuticals announced in May.
Court Approves 23andMe Sale to Ex-CEO's Nonprofit